News Formal

Sanofi Becomes 3rd Insulin Maker to Announce Price Cap

  • 📰 WebMD
  • ⏱ Reading Time:
  • 21 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 12%
  • Publisher: 51%

Business Business Headlines News

Business Business Latest News,Business Business Headlines

Sanofi announced that it will cut the list price of its U.S. insulin drug, Lantus, by 78% and will cap the cost of the drug at $35 per month for people with private insurance, making it the third major insulin provider to cut costs for consumers.

, the company also said it will cut the list price of its short-acting insulin Apidra by 70%. Sanofi offers uninsured Americans a $35 insulin cap through its Valyou Savings Program.Health advocates have long urged pharmaceutical companies to reduce the cost of insulin, which is relatively inexpensive to manufacture. The companies acted after the Inflation Reduction Act capped Medicare copays for insulin at $35 per month.

. “Sanofi is the latest company to recognize that charging hundreds of dollars for insulin that costs $10 to produce is just wrong, especially when the lives of so many children, parents, and grandparents depend on it.”more than 37 million Americans are living with diabetes and 8.4 million of them rely on insulin to survive. The drug helps regulate blood sugar in people who have type 1 and type 2 diabetes.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Why are you showing a Novolog pen instead of a Lantus pen!

aftab_usa Trump already did that remember?

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 709. in BUSİNESS

Business Business Latest News, Business Business Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Sanofi to cut U.S. insulin prices by up to 78%, capping cost at $35Sanofi is cutting the list price of Lantus, its most widely prescribed insulin in the US, by 78%, the company announced. Thanks Dark Brandon
Source: ABC7NY - 🏆 592. / 51 Read more »

Sanofi to cut U.S. insulin prices by up to 78%, capping cost at $35Sanofi is cutting the list price of its insulin in the U.S. by 78%, establishing a $35 monthly cap for the privately insured.
Source: ABC7Chicago - 🏆 284. / 63 Read more »

Sanofi to cut U.S. insulin prices by up to 78%, capping cost at $35Sanofi is cutting the list price of Lantus, its most widely prescribed insulin in the US, by 78%, the company announced. Because California came out with its own insulin ThanksGav
Source: abc7newsbayarea - 🏆 529. / 51 Read more »

Sanofi to cut U.S. insulin prices by up to 78%, capping cost at $35Sanofi is cutting the list price of Lantus, its most widely prescribed insulin in the US, by 78%, the company announced.
Source: 6abc - 🏆 250. / 63 Read more »